GSK Data Science Team
Episode notes
In this web event, you’ll learn:
- GSK’s Open-Source Commitment and Journey: Discover how GSK began their journey with open-source software, particularly R, and the pilots they’ve initiated to foster broader acceptance across the organization.
- Challenges and Goals in R Adoption: Understand the obstacles GSK faces in shifting to end-to-end use of R due to existing processes and timelines, and learn about their internal goals to achieve parity between R and other proprietary languages in their biostatistics toolkit.
- Evolution of Training Programs: See how GSK upskills teams through evolving training programs while meeting key deliverables.
- Contributing Back to Open-Source: Explore the importance GSK places on giving back to the open-source community as part of their adoption journey.
- Ascending the Open-Source Mountain: Join us to uncover the steps GSK has taken from pilot projects to setting large-scale enterprise adoption goals.
Stay tuned after the presentation for a live Q&A session, where you can ask the GSK team your pressing questions about open-source adoption in the pharmaceutical industry.
Featured in this episode
Phil is the Director of Healthcare and Life Sciences at Posit. His work focuses on innovation in the pharmaceutical industry, with an emphasis on interactive web applications, reproducible research and open-source education. He is interested in the use of R with applications in drug development and is a contributor to conferences promoting science through open data and software. He has experience at a number of technology and consulting corporations working in data science teams and delivering innovative data products. Phil has over 10 years’ experience implementing analytical programs, specializing in interactive web application initiatives and reporting needs for life science companies.
Data Scientist with 12+ years of technology driven solutions experience in the public, private, and social sector. Currently, a Director of Data Science at GSK focused on data science enablement and open source solutions. Considerable experience in implementing data science solutions, either in the form of transformational efforts in data science strategy, new market entry or new business model development; to more tactical changes, such as machine learning optimization, data visualization improvements, technology platform development, system integration, and operational risk analysis.
With over 14 years in clinical research, Becca is a biostatistician by training who specializes in developing R-based tools. Her expertise bridges statistical theory and practical application, ensuring GSK's biostatistics remains innovative.